What is the current valuation of the China whole exome-sequencing market?

The market valuation was $151.45 Million in 2024. Read More

What is the projected market size for the China whole exome-sequencing market by 2035?

The market is expected to reach $1147.35 Million by 2035. Read More

What is the expected CAGR for the China whole exome-sequencing market during the forecast period 2025 - 2035?

The expected CAGR is 20.21% during the forecast period. Read More

Which companies are the key players in the China whole exome-sequencing market?

Key players include Illumina, Thermo Fisher Scientific, BGI Genomics, and Roche. Read More

What are the main product segments in the China whole exome-sequencing market?

Main product segments include kits, systems, and services, with valuations ranging from $30.0 Million to $547.35 Million. Read More

What technologies are driving the China whole exome-sequencing market?

Technologies include sequencing by synthesis (SBS) and ION semiconductor sequencing, valued between $61.45 Million and $680.0 Million. Read More

What applications are prominent in the China whole exome-sequencing market?

Prominent applications include diagnostics, drug discovery, and agriculture, with valuations from $40.87 Million to $460.0 Million. Read More

Who are the primary end-users of whole exome-sequencing in China?

Primary end-users include research centers, hospitals, and pharmaceutical companies, with valuations from $30.0 Million to $527.35 Million. Read More

How does the market performance of services compare to other product segments?

Services are projected to reach $547.35 Million, indicating strong demand compared to kits and systems. Read More

What trends are anticipated in the China whole exome-sequencing market by 2035?

Trends suggest substantial growth driven by advancements in technology and increasing applications in healthcare and agriculture. Read More

China Whole Exome Sequencing Market

ID: MRFR/HC/48274-HCR

200 Pages

Satyendra Maurya

Last Updated: April 06, 2026

China Whole Exome Sequencing Market Research Report By Products (Kits, Sequencer, Services), By Technology (Sequencing by Synthesis (SBS), ION Semiconductor Sequencing), By Application (Diagnostics, Drug Discovery and Development, Agriculture and Animal Research) and By End-User (Research Centers and Government Institutes, Hospitals and Diagnostics Centers, Pharmaceuticals & Biotechnology Companies) - Growth & Industry Forecast 2025 To 2035

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 Healthcare, BY Product (USD Million)
  1. 4.1.1 kits
  2. 4.1.2 systems
  3. 4.1.3 services
2. 4.2 Healthcare, BY Technology (USD Million)
  1. 4.2.1 sequencing by synthesis (SBS)
  2. 4.2.2 ION semiconductor sequencing
3. 4.3 Healthcare, BY Application (USD Million)
  1. 4.3.1 diagnostics
  2. 4.3.2 drug discovery and development
  3. 4.3.3 agriculture and animal research
4. 4.4 Healthcare, BY End-User (USD Million)
  1. 4.4.1 research centers and government institutes
  2. 4.4.2 hospitals and diagnostics centers
  3. 4.4.3 pharmaceuticals & biotechnology companies
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the Healthcare
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the Healthcare
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Illumina (US)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Thermo Fisher Scientific (US)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 BGI Genomics (CN)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Agilent Technologies (US)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Roche (CH)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 PerkinElmer (US)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Macrogen (KR)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 Eurofins Scientific (LU)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
  9. 5.2.9 Fulgent Genetics (US)
    1. 5.2.9.1 Financial Overview
    2. 5.2.9.2 Products Offered
    3. 5.2.9.3 Key Developments
    4. 5.2.9.4 SWOT Analysis
    5. 5.2.9.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 CHINA MARKET ANALYSIS BY PRODUCT
3. 6.3 CHINA MARKET ANALYSIS BY TECHNOLOGY
4. 6.4 CHINA MARKET ANALYSIS BY APPLICATION
5. 6.5 CHINA MARKET ANALYSIS BY END-USER
6. 6.6 KEY BUYING CRITERIA OF HEALTHCARE
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF HEALTHCARE
9. 6.9 DRIVERS IMPACT ANALYSIS: HEALTHCARE
10. 6.10 RESTRAINTS IMPACT ANALYSIS: HEALTHCARE
11. 6.11 SUPPLY / VALUE CHAIN: HEALTHCARE
12. 6.12 HEALTHCARE, BY PRODUCT, 2024 (% SHARE)
13. 6.13 HEALTHCARE, BY PRODUCT, 2024 TO 2035 (USD Million)
14. 6.14 HEALTHCARE, BY TECHNOLOGY, 2024 (% SHARE)
15. 6.15 HEALTHCARE, BY TECHNOLOGY, 2024 TO 2035 (USD Million)
16. 6.16 HEALTHCARE, BY APPLICATION, 2024 (% SHARE)
17. 6.17 HEALTHCARE, BY APPLICATION, 2024 TO 2035 (USD Million)
18. 6.18 HEALTHCARE, BY END-USER, 2024 (% SHARE)
19. 6.19 HEALTHCARE, BY END-USER, 2024 TO 2035 (USD Million)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 China MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY PRODUCT, 2025-2035 (USD Million)
  2. 7.2.2 BY TECHNOLOGY, 2025-2035 (USD Million)
  3. 7.2.3 BY APPLICATION, 2025-2035 (USD Million)
  4. 7.2.4 BY END-USER, 2025-2035 (USD Million)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

China China Whole Exome Sequencing Market Segmentation

China Whole Exome Sequencing Market By Product (USD Million, 2025-2035)

kits
systems
services

China Whole Exome Sequencing Market By Technology (USD Million, 2025-2035)

sequencing by synthesis (SBS)
ION semiconductor sequencing

China Whole Exome Sequencing Market By Application (USD Million, 2025-2035)

diagnostics
drug discovery and development
agriculture and animal research

China Whole Exome Sequencing Market By End-User (USD Million, 2025-2035)

research centers and government institutes
hospitals and diagnostics centers
pharmaceuticals & biotechnology companies

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”